Efpeglenatide: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
CSV import |
||
| Line 3: | Line 3: | ||
{{dictionary-stub2}} | {{dictionary-stub2}} | ||
{{short-articles-ni}} | {{short-articles-ni}} | ||
{{No image}} | |||
Latest revision as of 16:22, 10 February 2025
Definition

Efpeglenatide:long-acting glucagon-like peptide 1 receptor agonist, with glucose- and weight-lowering effects, in development for type 2 diabetes (T2D)
This concise article on Efpeglenatide incorporates public domain text from the US National Library of Medicine.
| This article is a stub. You can help WikiMD by registering to expand it. |